Regulation of matrix biology by matrix metalloproteinases

Current Opinion in Cell Biology

Volumn 16, Issue 5, 2004, Pages 558-564

  Mott, Joni D ^a   Werb, Zena ^b  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ADAM; ADAM TS; an ADAM with a thrombospondin like motif; BMP; bone morphogenetic protein; CR; cysteine rich; ECM; extracellular matrix; LAP; latency associated peptide; latent TGF binding protein; LTBP; protein with a disintegrin and metalloprotease domain

Indexed keywords

GELATINASE A; GELATINASE B; GROWTH FACTOR; MATRILYSIN; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE;

ANGIOGENESIS; CYTOARCHITECTURE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW;

BASEMENT MEMBRANE; EXTRACELLULAR MATRIX; GROWTH SUBSTANCES; MATRIX METALLOPROTEINASES; MODELS, BIOLOGICAL; PEPTIDE FRAGMENTS;

EID: 4444304939     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2004.07.010     Document Type: Review

References (55)

1. C.K. Miranti, and J.S. Brugge Sensing the environment: a historical perspective on integrin signal transduction Nat Cell Biol 4 2002 83 90
2. D.E. Michele, and K. Campbell Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function J Biol Chem 278 2003 15457 15460
3. A. Yoneda, and J.R. Couchman Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans Matrix Biol 22 2003 25 33
4. R.O. Hynes Integrins: bidirectional, allosteric signaling machines Cell 110 2002 673 687
5. L.J. McCawley, and L.M. Matrisian Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 13 2001 534 540
6. S. Schenk, and V. Quaranta Tales from the cryptic sites of the extracellular matrix Trends Cell Biol 13 2003 366 375 This is a comprehensive review describing cryptic bioactive fragments from ECM proteins.
7. N. Ortega, and Z. Werb New functional roles for non-collagenous domains of basement membrane collagens J Cell Sci 115 2002 4201 4214
8. M.D. Sternlicht, and Z. Werb How matrix metalloproteinases regulate cell behavior Annu Rev Cell Dev Biol 17 2001 463 516
9. J.A. Martignetti, A. Al Aqeel, W. Al Sewairi, C.E. Boumah, M. Kambouris, S. Al Mayouf, K.V. Sheth, W. Al Eid, O. Dowling, and J. Harris Mutation of the matrix metalloproteinase 2 gene (MMP-2) causes a multicentric osteolysis and arthritis syndrome Nat Genet 28 2001 261 264
10. T.H. Vu Don't mess with the matrix Nat Genet 28 2001 202 203
11. M. Hangai, N. Kitaya, J. Xu, C.K. Chan, J.J. Kim, Z. Werb, S.J. Ryan, and P.C. Brooks Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis Am J Pathol 161 2002 1429 1437
12. J. Xu, D. Rodriguez, E. Peticlerc, J.J. Kim, M. Hangai, S.M. Yuen, G.E. Davis, and P.C. Brooks Proteolytic exposure of a cryptic site within collagen Type IV is required for angiogenesis and tumor growth in vivo J Cell Biol 154 2001 1069 1079
13. R. Kalluri Basement membranes: structure, assembly and role in tumor angiogenesis Nat Rev Cancer 3 2003 422 433
14. Y. Hamano, M. Zeisberg, H. Sugimoto, J.C. Lively, Y. Maeshima, C. Yang, R.O. Hynes, Z. Werb, A. Sudhakar, and R. Kalluri Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin Cancer Cell 3 2003 589 601 This is an in vivo study showing that tumstatin is a physiologically functional angiogenesis inhibitor that is released from collagen IV by MMP-9 cleavage.
15. M. Mongiat, S.M. Sweeney, J.D. San Antonio, J. Fu, and R.V. Iozzo Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of Perlecan J Biol Chem 278 2003 4238 4249
16. C. Gilles, M. Polette, C. Coraux, J.-M. Tournier, G. Meneguzzi, C. Munaut, L. Volders, P. Rouselle, P. Birembaut, and J.-M. Foidart Contribution of MT1-MMP and of human laminin-5 γ2 chain degradation to mammary epithelial cell migration J Cell Sci 114 2001 2967 2976
17. N. Koshikawa, G. Giannelli, V. Cirulli, K. Migyazaki, and V. Quaranta Role of cell surface metalloproteinase MT1-MMP in epithelial cell migration over Laminin-5 J Cell Biol 148 2000 615 625
18. S. Schenk, E. Hintermann, M. Bilban, N. Koshikawa, C. Hojilla, R. Khokha, and V. Quaranta Binding to EGF receptor of a Laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution J Cell Biol 161 2003 197 209
19. K. Holmbeck, P. Bianco, J. Caterina, S. Yamada, M. Kromer, S.A. Kuznetsov, M. Mankani, P.G. Robey, R.A. Poole, and I. Pidoux MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover Cell 99 1999 81 92
20. N. Koshikawa, S. Schenk, G. Moeckel, A. Sharabi, K. Miyazaki, H. Gardner, R. Zent, and V. Quaranta Proteolytic processing of taminin-5 by MT1-MMP in tissues and its effects on epithelial cell morphology FASEB J 18 2004 364 366
21. E. Pirila, A. Sharabi, T. Salo, V. Quaranta, H. Tu, R. Heljasvaara, N. Koshikawa, T. Sorsa, and P. Maisi Matrix metalloproteinases process the laminin-5 γ2-chain and regulate epithelial cell migration Biochem Biophys Res Commun 303 2003 1012 1017 This study identifies the sites in laminin-5 that are cleaved by MMPs and shows that the specificity of the cleavage site is important for bioactivity of the cryptic laminin-5 fragment.
22. S.L. Schor, I.R. Ellis, S.J. Jones, R. Baillie, K. Seneviratne, J. Clausen, K. Motegi, B. Vojtesek, K. Kankova, and E. Furrie Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells Cancer Res 63 2003 8827 8836
23. J.E. Park, G.A. Keller, and N. Ferrara The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF Mol Biol Cell 4 1993 1317 1326
24. G. Bergers, R. Brekken, G. McMahon, T.H. Vu, T. Itoh, K. Tamaki, K. Tanzawa, P. Thorpe, S. Itohara, and Z. Werb Matrix metalloproteinase 9 triggers the angiogenic switch during carcinogenesis Nat Cell Biol 2 2000 737 744
25. D. Belotti, P. Paganoni, L. Manenti, A. Garofalo, S. Marchini, G. Taraboletti, and R. Giavazzi Matrix metalloproteinases (MMP-9 and MMP-2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation Cancer Res 63 2003 5224 5229
26. J.P. Annes, J.S. Munger, and D.B. Rifkin Making sense of latent TGFβ activation J Cell Sci 116 2003 217 224
27. Q. Yu, and I. Stamenkovic Cell-surface-localized matrix metalloproteinase 9 proteolytically activates TGFβ and promotes tumor invasion and angiogenesis Genes Dev 14 2000 163 176
28. D. Mu, S. Cambier, L. Fjellbirkeland, J.L. Baron, J.S. Munger, H. Kawakatsu, D. Sheppard, V.C. Broaddus, and S.L. Nishimura The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGFβ1 J Cell Biol 157 2002 493 507
29. M. Dangelo, D.P. Sarment, P.C. Billings, and M. Pacifici Activation of transforming growth factor β in chondrocytes undergoing endochondral ossification J Bone Miner Res 16 2001 2339 2347
30. S.L. Dallas, J.L. Rosser, G.R. Mundy, and L.F. Bonewald Proteolysis of latent transforming growth factor-β (TGF-β)-binding protein-1 by osteoclasts J Biol Chem 277 2002 21352 21360 This work identifies LTBP as a novel substrate for MMPs and show that proteolysis may be the first step in the activation of growth factors sequestered in the ECM.
31. S. Maeda, D.D. Dean, R. Gomez, Z. Schwartz, and B.D. Boyan The first stage of transforming growth factor β 1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle Stromelysin-1 (MMP-3) Calcif Tissue Int 70 2002 54 65
32. E. Neptune, P.A. Frischmeyer, D.E. Arking, L. Myers, T.E. Bunton, B. Gayraud, F. Ramirez, L.Y. Sakai, and H.C. Dietz Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome Nat Genet 33 2003 407 411 This work shows that matrix sequestration of cytokines is a critical point for the regulation of their activity.
33. J.G. Abreu, C. Coffinier, J. Larrain, M. Oelgeschlager, and E.M. DeRobertis Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems Gene 287 2002 39 47
34. H. Yamada, F. Saito, H. Fukuta-Ohi, D. Zhong, A. Hase, K. Arai, A. Okuyama, R. Maekawa, T. Shimizu, and K. Matsumura Processing of β-dystroglycan by matrix metalloproteinases disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex Hum Mol Genet 10 2001 1563 1569
35. M.L. Fitzgerald, Z. Wang, P.W. Park, G. Murphy, and M. Bernfield Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a timp-3 sensitive metalloproteinase J Cell Biol 148 2000 811 824
36. K. Endo, T. Takino, H. Miyamori, H. Kinsen, T. Yoshizaki, M. Furukawa, and H. Sato Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration J Biol Chem 278 2003 40764 40770
37. B.Y. Liu, Y.C. Kim, V. Leatherberry, P. Cowin, and C.M. Alexander Mammary gland development requires syndecan-1 to create a β-catenin/TCF-responsive mammary epithelial subpopulation Oncogene 22 2003 9243 9253
38. B.Y. Liu, S.P. McDermott, S.S. Khwaja, and C.M. Alexander The transforming activity of wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells Proc Natl Acad Sci USA 101 2004 4158 4163
39. A.H. Beare, S. O'Kane, S.M. Krane, and M.W. Ferguson Severely impaired wound healing in the collagenase-resistant mouse J Invest Dermatol 120 2003 153 163
40. R. Chiusaroli, A. Maier, M.C. Knight, M. Byrne, L.M. Calvi, R. Baron, S.M. Krane, and E. Schipani Collagenase cleavage of type I collagen is essential for both basal and parathyroid hormone (PTH)/PTH-related peptide receptor-induced osteoclast activation and has differential effects on discrete bone compartments Endocrinology 144 2003 4106 4116
41. M.L. Lindsey, J. Yoshioka, C. MacGillivray, S. Muangman, J. Gannon, A. Verghese, M. Aikawa, P. Libby, S.M. Krane, and R.T. Lee Effect of a cleavage-resistant collagen mutation on left ventricular remodeling Circ Res 93 2003 238 245
42. H. Stanton, and A.J. Fosang Matrix metalloproteinases are active following guanidine hydrochloride extraction of cartilage: generation of DIPEN neoepitope during dialysis Matrix Biol 21 2002 425 428
43. Q. Chu, M. Lopez, K. Hayashi, M. Ionescu, R.C. Billinghurst, K.A. Johnson, R.A. Poole, and M.D. Markel Elevation of collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog Osteoarthritis Cartilage 10 2002 662 669
44. N. Ishiguro, T. Ito, T. Oguchi, T. Kojima, H. Iwata, M. Ionescu, and R.A. Poole Relationships of matrix metalloproteinases and their inhibitors to cartilage proteoglycan and collagen turnover and inflammation as revealed by analyses of synovial fluids from patients with rheumatoid arthritis Arthritis Rheum 44 2001 2503 2511
45. A.J. Fosang, K. Last, D.C. Jackson, and L. Brown Antibodies to MMP-cleaved aggrecan Methods Mol Biol 151 2001 425 449
46. M. Strazynski, J.A. Eble, H. Kresse, and E. Schonherr Interleukin (IL)-6 and IL-10 induce DEcoRIn mRNA in endothelial cells, but interaction with fibrillar collagen is essential for its translation J Biol Chem 279 2004 21266 21270
47. P.C. Coloradao, A. Torre, G. Kamphaus, Y. Maeshima, H. Hopfter, K. Takahashi, R. Volk, E.D. Amborsky, S. Herman, and P.K. Sarkar Anti-angiogenic cues from vascular basement membrane collagen Cancer Res 60 2000 2520 2526
48. G.D. Kamphaus, P.C. Coloradao, D.J. Panka, H. Hopfter, R. Ramchandran, A. Torre, Y. Maeshima, J.W. Mier, V.P. Sukhatme, and R. Kalluri Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth J Biol Chem 275 2000 1209 1215
49. E. Peticlerc, A. Boutaud, A. Prestayko, J. Xu, S. Yoshikazu, Y. Ninomiya, P. Maichael, J. Sarras, B.G. Hudson, and P.C. Brooks New functions for non-collagenous domains of human collagen type IV J Biol Chem 275 2000 8051 8061
50. Y. Maeshima, P.C. Colorado, and R. Kalluri Two RGD-independent αvβ3 integrin binding sites on tumstatin regulate distinct anti-tumor properties J Biol Chem 275 2000 23745 23750
51. R. Xu, Z.Y. Yao, L. Xin, Q. Zhang, T.P. Li, and R.B. Gan NC1 domain of human type VIII collagen (α 1) inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis Biochem Biophys Res Commun 289 2001 264 268
52. R. Ramchandran, M. Dhanabal, R. Volk, M.J. Waterman, M. Segal, H. Lu, B. Knebelmann, and V.P. Sukhatme Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin Biochem Biophys Res Commun 255 1999 735 739
53. M.S. O'Reilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios, W.S. Lane, E. Flynn, J.R. Birkhead, B.R. Olsen, and J. Folkman Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 1997 277 285
54. G.E. Davis, K.J. Bayless, M.J. Davis, and G.A. Meininger Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules Am J Pathol 156 2000 1489 1498
55. S.L. Schor, and A.M. Schor Tumour-stromal interactions: phenotypic and genetic alterations in mammary stroma - implications for tumour progression Breast Cancer Res 3 2001 373 379